Back to search results

Substance Abuse Pre-Treatment Screening Study

This study is an observational study for people seeking treatment for substance abuse, including cocaine, opiates, and alcohol. It aims to connect you with the most suitable clinical trial or study for your needs. While this study itself doesn't test specific treatments, the overall project involves drugs like modafinil, d-amphetamine, L-Dopa, and Naltrexone in other related trials. To join, you must be 18 to 60 years old, seeking treatment, and generally healthy. Success in this screening study means being directed to an appropriate treatment study. The current status of this study is unclear.

Study design
This is an observational study planning to enroll 7500 participants. It's designed to screen potential participants for other treatment studies.
What's involved
You would undergo a one-day evaluation including a medical, social, psychiatric, and drug use history. This evaluation helps determine if you qualify for other treatment studies.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT00439049

Substance Abuse Pre-Treatment Screening Study

UNKNOWN
Not specifiedAges 18–60Observational
The University of Texas Health Science Center, Houston
~7,500 participants
Updated 2023-12-20 on ClinicalTrials.gov
What's tested:modafinild-amphetamineL-DopaNaltrexone

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Urine Toxicology
Measured over 6 weeks to 24 weeks

Conditions

Cocaine Abuse
Cocaine Dependence
Opiate Dependence
Alcohol Dependence
Substance Abuse

Explore related trials

Alcohol DependenceCocaine DependenceHarmful pattern of use of cocaineOpioid-Related DisordersSubstance Abuse

Where it's being run

1 sites across 1 states
Texas1

Study leadership

  • Joy M. Schmitz, PhD · PRINCIPAL_INVESTIGATOR · The University of Texas Health Science Center, Houston
  • Frederick G Moeller, MD · PRINCIPAL_INVESTIGATOR · The University of Texas Health Science Center, Houston
  • Angela L Stotts, PhD · PRINCIPAL_INVESTIGATOR · The University of Texas Health Science Center, Houston

Who to contact

Jessica Vincent, BS
[email protected]
713-486-2803
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Willing and able to participate in 3- to 6-month treatment program.
At least 18 years of age.
Seeking treatment for substances of abuse including (cocaine, opiates, and alcohol).
Generally physically healthy.

Exclusion

Pregnant or breastfeeding.
Mandated by the courts/parole officers to attend treatment.
Not seeking treatment for substances of abuse.
Plans to move from the Houston area within the 3- to 6-month treatment period.
Seeking treatment for a substance for which the Treatment Research Clinic (TRC) has no current trial.

What this trial measures

  • Urine Toxicology6 weeks to 24 weeks